. home.aspx

NEWS

home.aspx
   


Research shows the pharma industry believes AI will likely optimise R&D

December 10, 2019 / European Pharmaceutical Review
SHARESHARESHARE

A survey has shown that the pharmaceutical industry believes R&D will see a lot of benefit from digital transformation and that AI will be at the forefront of this. New research has shown that the global pharmaceutical industry spends a significant amount of revenue on research and development (R&D) activities that are failing to deliver projected returns but that digital transformation with artificial intelligence (AI) is seen as a major step forward towards enhancing R&D productivity and effectiveness.